Nitric oxide induces HIF-1α stabilization and expression of intestinal trefoil factor in the damaged rat jejunum and modulates ulcer healing

Journal of Gastroenterology

Volumn 46, Issue 5, 2011, Pages 565-576

  Riano A ^a   Ortiz Masia D ^a   Velazquez M ^a   Calatayud, S ^a   Esplugues, J V ^a   Barrachina, Maria Dolores ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

HIF 1; Indomethacin; Intestinal damage; ITF; Nitric oxide; Nitrosylation

Indexed keywords

ANTIBODY; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTESTINAL TREFOIL FACTOR; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE; NITROCYSTEINE ANTIBODY; NITROTYROSINE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GOBLET CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INTESTINE EPITHELIUM; INTESTINE INJURY; JEJUNUM INJURY; MALE; NITRATION; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN STABILITY; RAT; ULCER HEALING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GOBLET CELLS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMINES; IMMUNOPRECIPITATION; INDOMETHACIN; INTESTINAL MUCOSA; JEJUNUM; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PEPTIC ULCER; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 79958698482     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0374-1     Document Type: Article

References (39)

1. Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky DK. Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest. 1994;94:376-83. (Pubitemid 24218114)
2. Playford RJ, Marchbank T, Chinery R, Evison R, Pignatelli M, Boulton RA, et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology. 1995;108:108-16.
3. Kato K, Chen MC, Nguyen M, Lehmann FS, Podolsky DK, Soll AH. Effects of growth factors and trefoil peptides on migration and replication in primary oxyntic cultures. Am J Physiol. 1999;276:G1105-16.
4. Hoffmann W. Trefoil factors TFF (trefoil factor family) peptide-triggered signals promoting mucosal restitution. Cell Mol Life Sci. 2005;62:2932-8. (Pubitemid 43004746)
5. Kjellev S. The trefoil factor family - small peptides with multiple functionalities. Cell Mol Life Sci. 2009;66:1350-69.
6. Longman RJ, Douthwaite J, Sylvester PA, Poulsom R, Corfield AP, Thomas MG, et al. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut. 2000;47:792-800.
7. Furuta GT, Turner JR, Taylor CT, Hershberg RM, Comerford K, Narravula S, et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med. 2001;193:1027-34. (Pubitemid 32436196)
8. Hernandez C, Santamatilde E, McCreath KJ, Cervera AM, Diez I, Ortiz-Masia D, et al. Induction of trefoil factor (TFF)1, TFF2 and TFF3 by hypoxia is mediated by hypoxia inducible factor-1: implications for gastric mucosal healing. Br J Pharmacol. 2009;156:262-72.
9. Bruick RK. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev. 2003;17:2614-23. (Pubitemid 37363065)
10. Lando D, Gorman JJ, Whitelaw ML, Peet DJ. Oxygen-dependent regulation of hypoxia-inducible factors by prolyl and asparaginyl hydroxylation. Eur J Biochem. 2003;270:781-90. (Pubitemid 36315321)
11. Sandau KB, Fandrey J, Brune B. Accumulation of HIF-1alpha under the influence of nitric oxide. Blood. 2001;97:1009-15. (Pubitemid 32154286)
12. Sogawa K, Numayama-Tsuruta K, Ema M, Abe M, Abe H, Fujii-Kuriyama Y. Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia. Proc Natl Acad Sci USA. 1998; 95:7368-73. (Pubitemid 28293258)
13. Yin JH, Yang DI, Ku G, Hsu CY. iNOS expression inhibits hypoxia-inducible factor-1 activity. Biochem Biophys Res Commun. 2000;279:30-4.
14. Agani FH, Puchowicz M, Chavez JC, Pichiule P, LaManna J. Role of nitric oxide in the regulation of HIF-1alpha expression during hypoxia. Am J Physiol Cell Physiol. 2002;283:C178-86.
15. Bove PF, Hristova M, Wesley UV, Olson N, Lounsbury KM, van der Vliet A. Inflammatory levels of nitric oxide inhibit airway epithelial cell migration by inhibition of the kinase ERK1/2 and activation of hypoxia-inducible factor-1 alpha. J Biol Chem. 2008;283(26):17919-28.
16. Mateo J, Garcia-Lecea M, Cadenas S, Hernandez C, Moncada S. Regulation of hypoxia-inducible factor-1alpha by nitric oxide through mitochondria-dependent and -independent pathways. Biochem J. 2003;376:537-44. (Pubitemid 38010539)
17. Li F, Sonveaux P, Rabbani ZN, Liu S, Yan B, Huang Q, et al. Regulation of HIF-1alpha stability through S-nitrosylation. Mol Cell. 2007;26:63-74. (Pubitemid 46550936)
18. Ito M, Tanaka S, Kim S, Kuwai T, Matsutani N, Kamada T, et al. The specific expression of hypoxia inducible factor-1alpha in human gastric mucosa induced by nonsteroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2003;18(Suppl 1):90-8. (Pubitemid 36898004)
19. Ortiz-Masia D, Hernandez C, Quintana E, Velazquez M, Cebrian S, Riano A, et al. iNOS-derived nitric oxide mediates the increase in TFF2 expression associated with gastric damage: role of HIF-1. FASEB J. 2010;24:136-45.
20. Kane S, Lu F, Kornbluth A, Awais D, Higgins PD. Controversies in mucosal healing in ulcerative colitis. Inflamm Bowel Dis. 2009;15:796-800.
21. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999;17:1474-81. (Pubitemid 29220854)
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-5.
23. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem. 1993;214:11-6. (Pubitemid 23300346)
24. Souza MH, Lemos HP, Oliveira RB, Cunha FQ. Gastric damage and granulocyte infiltration induced by indomethacin in tumour necrosis factor receptor 1 (TNF-R1) or inducible nitric oxide synthase (iNOS) deficient mice. Gut. 2004;53:791-6. (Pubitemid 38662127)
25. Akiba Y, Nakamura M, Mori M, Suzuki H, Oda M, Kimura H, et al. Inhibition of inducible nitric oxide synthase delays gastric ulcer healing in the rat. J Clin Gastroenterol. 1998;27(Suppl 1):S64-73.
26. Takeuchi K, Hatazawa R, Tanigami M, Tanaka A, Ohno R, Yokota A. Role of endogenous nitric oxide (NO) and NO synthases in healing of indomethacin-induced intestinal ulcers in rats. Life Sci. 2007;80:329-36. (Pubitemid 44958714)
27. Parasher G, Frenklakh L, Goodman, Siddiqui T, Nandi J, Levine RA. Nitric oxide inhibitors ameliorate indomethacin-induced enteropathy in rats. Dig Dis Sci. 2001;46:2536-41. (Pubitemid 33042363)
28. Evans SM, Laszlo F, Whittle BJ. Site-specific lesion formation, inflammation and inducible nitric oxide synthase expression by indomethacin in the rat intestine. Eur J Pharmacol. 2000;388:281-5. (Pubitemid 30089853)
29. Nishida K, Ohta Y, Ishiguro I. Relation of inducible nitric oxide synthase activity to lipid peroxidation and nonprotein sulfhydryl oxidation in the development of stress-induced gastric mucosal lesions in rats. Nitric Oxide. 1998;2:215-23. (Pubitemid 29016151)
30. Metzen E, Zhou J, Jelkmann W, Fandrey J, Brune B. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol Biol Cell. 2003;14:3470-81. (Pubitemid 37013142)
31. Brune B, Zhou J. Nitric oxide and superoxide: interference with hypoxic signaling. Cardiovasc Res. 2007;75:275-82. (Pubitemid 46961919)
32. Mylonis I, Chachami G, Samiotaki M, Panayotou G, Paraskeva E, Kalousi A, et al. Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha. J Biol Chem. 2006;281:33095-106. (Pubitemid 46043259)
33. Diez I, Calatayud S, Hernandez C, Quintana E, O'Connor JE, Esplugues JV, et al. Nitric oxide, derived from inducible nitric oxide synthase, decreases hypoxia inducible factor-1alpha in macrophages during aspirin-induced mesenteric inflammation. Br J Pharmacol. 2010;159(8):1636-45.
34. Semenza GL. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol. 2001;13:167-71. (Pubitemid 32209217)
35. Erusalimsky JD, Moncada S. Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. Arterioscler Thromb Vasc Biol. 2007;27:2524-31. (Pubitemid 350158901)
36. Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol. 2003;4:721-32. (Pubitemid 37082187)
37. Anand RJ, Gribar SC, Li J, Kohler JW, Branca MF, Dubowski T, et al. Hypoxia causes an increase in phagocytosis by macrophages in a HIF-1alpha-dependent manner. J Leukoc Biol. 2007;82:1257-65. (Pubitemid 350133524)
38. Louis NA, Hamilton KE, Canny G, Shekels LL, Ho SB, Colgan SP. Selective induction of mucin-3 by hypoxia in intestinal epithelia. J Cell Biochem. 2006;99:1616-27. (Pubitemid 44845721)
39. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, et al. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood. 2000;95:189-97. (Pubitemid 30017242)